0001209191-23-049508.txt : 20230914 0001209191-23-049508.hdr.sgml : 20230914 20230914193154 ACCESSION NUMBER: 0001209191-23-049508 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230914 FILED AS OF DATE: 20230914 DATE AS OF CHANGE: 20230914 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TAGLIAFERRI MARY CENTRAL INDEX KEY: 0001323304 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41799 FILM NUMBER: 231256272 MAIL ADDRESS: STREET 1: 455 MISSION BAY BOULEVARD SOUTH CITY: SAN FRANCISCO STATE: CA ZIP: 94158 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RayzeBio, Inc. CENTRAL INDEX KEY: 0001825367 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5505 MOREHOUSE DRIVE, SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (619) 937-2754 MAIL ADDRESS: STREET 1: 5505 MOREHOUSE DRIVE, SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92121 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2023-09-14 0 0001825367 RayzeBio, Inc. RYZB 0001323304 TAGLIAFERRI MARY C/O RAYZEBIO, INC. 5505 MOREHOUSE DRIVE, SUITE 300 SAN DIEGO CA 92121 1 0 0 0 Employee Stock Option (Right to Buy) 3.24 2031-09-28 Common Stock 73731 D Employee Stock Option (Right to Buy) 3.24 2032-11-30 Common Stock 40848 D The option is subject to an early exercise provision and is immediately exercisable. Vesting is monthly over a 36-month period starting October 29, 2021 in equal monthly amounts. The option is subject to an early exercise provision and is immediately exercisable. Vesting is monthly over a 36-month period starting January 1, 2023 in equal monthly amounts. Exhibit 24 - Power of Attorney /s/ Jeff Woodley, Attorney-in-fact 2023-09-14 EX-24 2 poa.txt POA DOCUMENT POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of Carlos Ramirez, Terren O'Connor, Michelle L. Hunt and Albert Gelin of Cooley LLP, and Kenneth Song and Jeff Woodley of RayzeBio, Inc. (the "Company"), signing individually, the undersigned's true and lawful attorney-in fact and agent to: (1) Prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the Securities and Exchange Commission (the "SEC"), a Form ID and Forms 3, 4 and 5 (including amendments thereto and joint filing agreements in connection therewith) in accordance with Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the rules thereunder, in the undersigned's capacity as an officer, director or beneficial owner of more than 10% of a registered class of securities of the Company; (2) Do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to complete and execute such Form ID and Forms 3, 4 or 5 (including amendments thereto and joint filing agreements in connection therewith), and file such forms or amendments with the SEC and any stock exchange, self-regulatory association or any similar authority; and (3) Take any other action of any nature whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-facts discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-facts substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that each of the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act. This Power of Attorney shall remain in full force and effect until the earliest to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, (b) revocation by the undersigned in a signed writing delivered to the foregoing attorney-in-fact or (c) as to any attorney-in-fact individually, until such attorney-in-fact is no longer employed by the Company or employed by or a partner at Cooley LLP or another law firm representing the Company, as applicable. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 1st day of September, 2023. /s/ Mary Tagliaferri, M.D.